Rice Hall James & Associates LLC Increases Stock Position in Avanos Medical, Inc. (NYSE:AVNS)

Rice Hall James & Associates LLC boosted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 106.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 128,059 shares of the company's stock after purchasing an additional 65,930 shares during the quarter. Rice Hall James & Associates LLC owned about 0.28% of Avanos Medical worth $1,835,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of AVNS. Quantbot Technologies LP purchased a new stake in Avanos Medical during the fourth quarter worth approximately $64,000. State of Wyoming grew its stake in Avanos Medical by 132.0% during the fourth quarter. State of Wyoming now owns 5,137 shares of the company's stock worth $82,000 after buying an additional 2,923 shares during the period. Tower Research Capital LLC TRC grew its stake in Avanos Medical by 493.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock worth $129,000 after buying an additional 6,714 shares during the period. EP Wealth Advisors LLC grew its stake in Avanos Medical by 14.6% during the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after buying an additional 1,289 shares during the period. Finally, Heritage Family Offices LLP purchased a new stake in Avanos Medical during the first quarter worth approximately $146,000. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Avanos Medical Trading Down 2.3%

AVNS traded down $0.27 during trading on Friday, hitting $11.37. 231,076 shares of the company's stock were exchanged, compared to its average volume of 503,159. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 1 year low of $11.21 and a 1 year high of $25.36. The stock has a 50 day moving average price of $12.35 and a 200 day moving average price of $13.90. The firm has a market cap of $525.61 million, a P/E ratio of -1.36 and a beta of 1.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. The business had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a negative net margin of 55.80% and a positive return on equity of 6.26%. The business's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 earnings per share. As a group, analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.